Extrawell Phar (00858) Issue under General Mandate Type: Issue under General Mandate Announcement Date: 2026-11-05 Summary: 精優藥業就根據一般授權配售新股份發佈補充公告,進一步說明配售所得款項淨額擬用於電子模組貿易及製造業務,但未披露配售價、股數或集資總額。